Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same author

Genomic Characterization of Classic Adamantinoma, Osteofibrous Dysplasia, and Osteofibrous Dysplasia-like Adamantinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Staged Resection with Temporizing VAC and Local Recurrence for Soft Tissue Sarcomas: A Multi-Institutional Review.

Cancers·2026
Same author

Team Approach: Diagnosis and Management of Pediatric Pelvic Ewing Sarcoma.

JBJS reviews·2026
Same author

Do Patients Who Undergo Conversion of Failed Osteoarticular Allografts to Megaprostheses Have Worse Outcomes Than Patients Treated With Primary Megaprostheses at Initial Resection?

Clinical orthopaedics and related research·2026
Same author

Inhibition of CDK9 sensitizes multidrug resistant ovarian cancer cells to paclitaxel.

Scientific reports·2026

Related Experiment Video

Updated: May 1, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

Non-neoplastic soft tissue masses that mimic sarcoma.

Matthew W Colman1, Santiago Lozano-Calderon1, Kevin A Raskin2

  • 1Department of Orthopedic Surgery, Massachusetts General Hospital, 55 Fruit Street, Yawkey 3B, Boston, MA 02114, USA; Department of Orthopedic Surgery, 330 Brookline Avenue, Boston, MA 02215, USA; Department of Orthopedic Surgery, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.

The Orthopedic Clinics of North America
|April 2, 2014
PubMed
Summary

Non-neoplastic soft tissue masses can resemble soft tissue sarcoma. Careful review of patient history, physical exam, imaging, labs, and biopsy helps differentiate these conditions.

Keywords:
ImitatorMimicSarcomaSoft tissue

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K

Related Experiment Videos

Last Updated: May 1, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K

Area of Science:

  • Oncology
  • Pathology
  • Radiology

Background:

  • Non-neoplastic soft tissue masses frequently present clinical challenges.
  • These benign conditions can mimic the presentation of soft tissue sarcoma.
  • Accurate differentiation is crucial for appropriate patient management.

Purpose of the Study:

  • To outline common non-neoplastic soft tissue entities that mimic sarcoma.
  • To provide characteristics aiding in the distinction between benign masses and malignancy.
  • To enhance diagnostic accuracy in soft tissue lesion evaluation.

Main Methods:

  • Review of patient history and clinical presentation.
  • Analysis of physical examination findings.
  • Correlation of imaging studies (e.g., MRI, ultrasound).
  • Evaluation of laboratory results.
  • Histopathological assessment of biopsy specimens.

Main Results:

  • Several non-neoplastic entities were identified as common mimics of soft tissue sarcoma.
  • Specific clinical, imaging, and pathological features were highlighted for differentiation.
  • A systematic approach facilitates distinguishing benign from malignant soft tissue masses.

Conclusions:

  • Comprehensive evaluation integrating multiple diagnostic modalities is key.
  • Understanding the characteristics of benign mimics improves diagnostic confidence.
  • Timely and accurate diagnosis prevents unnecessary aggressive treatment for benign conditions.